ATL/Interspec merger approved

Article

The merger of ultrasound vendorsATL and Interspec was approved this week by the shareholders ofboth companies. The companies announced the merger in February(SCAN 2/16/94). Under the terms of the merger, Interspec will become a whollyowned subsidiary

The merger of ultrasound vendorsATL and Interspec was approved this week by the shareholders ofboth companies. The companies announced the merger in February(SCAN 2/16/94).

Under the terms of the merger, Interspec will become a whollyowned subsidiary of ATL through an exchange of one share of Interspecstock for 0.413 shares of ATL stock. The acquisition creates anultrasound company with combined revenues of approximately $360million and an installed base of over 20,000 systems.

Interspec chief Edward Ray will continue as president of theAmbler, PA-based company and will join ATL's board of directors.ATL is based in Bothell, WA.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.